Joseph H. Korn

4.8k total citations
71 papers, 3.5k citations indexed

About

Joseph H. Korn is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Dermatology. According to data from OpenAlex, Joseph H. Korn has authored 71 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pathology and Forensic Medicine, 20 papers in Molecular Biology and 17 papers in Dermatology. Recurrent topics in Joseph H. Korn's work include Systemic Sclerosis and Related Diseases (30 papers), Dermatologic Treatments and Research (12 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers). Joseph H. Korn is often cited by papers focused on Systemic Sclerosis and Related Diseases (30 papers), Dermatologic Treatments and Research (12 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers). Joseph H. Korn collaborates with scholars based in United States, United Kingdom and Sweden. Joseph H. Korn's co-authors include Ante Jelaska, Robert W. Simms, Eugene Y. Kissin, Peter A. Merkel, Maureen D. Mayes, David Strehlow, James R. Seibold, Raphaël Lemaire, Harrison W. Farber and Sergio A. Jiménez and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Joseph H. Korn

71 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph H. Korn United States 36 1.5k 951 737 696 654 71 3.5k
Alfiya Akhmetshina Germany 29 1.4k 0.9× 1.7k 1.8× 587 0.8× 724 1.0× 664 1.0× 37 3.6k
Pawel Zerr Germany 31 1.3k 0.8× 1.6k 1.7× 486 0.7× 769 1.1× 662 1.0× 39 3.4k
Swati Bhattacharyya United States 34 1.5k 1.0× 1.4k 1.5× 543 0.7× 804 1.2× 760 1.2× 56 3.5k
Edwin A. Smith United States 42 1.9k 1.2× 1.3k 1.4× 692 0.9× 890 1.3× 519 0.8× 143 5.1k
Bashar Kahaleh United States 25 1.5k 1.0× 794 0.8× 588 0.8× 314 0.5× 591 0.9× 50 2.5k
Otylia Kowal‐Bielecka Poland 28 2.0k 1.3× 704 0.7× 721 1.0× 1.1k 1.5× 840 1.3× 110 3.2k
Alfiya Distler Germany 29 1.0k 0.7× 1.3k 1.3× 313 0.4× 622 0.9× 549 0.8× 55 2.9k
Monique Hinchcliff United States 36 1.9k 1.2× 840 0.9× 591 0.8× 953 1.4× 615 0.9× 97 3.5k
Francesco Del Galdo United Kingdom 31 1.2k 0.8× 789 0.8× 514 0.7× 453 0.7× 689 1.1× 176 2.8k
Astrid Jüngel Switzerland 37 1.1k 0.7× 2.1k 2.2× 453 0.6× 546 0.8× 1.1k 1.7× 67 4.6k

Countries citing papers authored by Joseph H. Korn

Since Specialization
Citations

This map shows the geographic impact of Joseph H. Korn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph H. Korn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph H. Korn more than expected).

Fields of papers citing papers by Joseph H. Korn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph H. Korn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph H. Korn. The network helps show where Joseph H. Korn may publish in the future.

Co-authorship network of co-authors of Joseph H. Korn

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph H. Korn. A scholar is included among the top collaborators of Joseph H. Korn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph H. Korn. Joseph H. Korn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kypriotou, Magdalini, Gallic Beauchef, Christos Chadjichristos, et al.. (2007). Human Collagen Krox Up-regulates Type I Collagen Expression in Normal and Scleroderma Fibroblasts through Interaction with Sp1 and Sp3 Transcription Factors. Journal of Biological Chemistry. 282(44). 32000–32014. 40 indexed citations
3.
Jun, Jae‐Bum, Melanie K. Kuechle, Jun‐Ki Min, et al.. (2005). Scleroderma Fibroblasts Demonstrate Enhanced Activation of Akt (Protein Kinase B) In Situ. Journal of Investigative Dermatology. 124(2). 298–303. 50 indexed citations
4.
Lemaire, Raphaël, Joseph H. Korn, J. Michael Shipley, & Robert Lafyatis. (2005). Increased expression of type I collagen induced by microfibril‐associated glycoprotein 2: Novel mechanistic insights into the molecular basis of dermal fibrosis in scleroderma. Arthritis & Rheumatism. 52(6). 1812–1823. 28 indexed citations
5.
Moreland, Larry W., Kevin R. King, Michael Weisman, et al.. (2001). Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis. Arthritis Research & Therapy. 3(4). 247–52. 41 indexed citations
6.
Korn, Joseph H. & Shamila Mauiyyedi. (2001). Case 26-2001. New England Journal of Medicine. 345(8). 596–605. 3 indexed citations
7.
Seibold, James R., Joseph H. Korn, Robert W. Simms, et al.. (2000). Recombinant Human Relaxin in the Treatment of Scleroderma. Annals of Internal Medicine. 44 indexed citations
8.
Jelaska, Ante, David Strehlow, & Joseph H. Korn. (2000). Fibroblast heterogeneity in physiological conditions and fibrotic disease. Springer Seminars in Immunopathology. 21(4). 385–395. 7 indexed citations
9.
Jelaska, Ante & Joseph H. Korn. (1998). Anti-fas induces apoptosis and proliferation in human dermal fibroblasts: Differences between foreskin and adult fibroblasts. Journal of Cellular Physiology. 175(1). 19–29. 54 indexed citations
10.
Strehlow, David & Joseph H. Korn. (1998). Biology of the scleroderma fibroblast. Current Opinion in Rheumatology. 10(6). 572–578. 46 indexed citations
11.
Widom, Russell L., et al.. (1997). Cloning and characterization of hcKrox, a transcriptional regulator of extracellular matrix gene expression. Gene. 198(1-2). 407–420. 51 indexed citations
13.
Stone, Phillip J., Joseph H. Korn, Edward V. Lally, et al.. (1995). Cross‐linked elastin and collagen degradation products in the urine of patients with scleroderma. Arthritis & Rheumatism. 38(4). 517–524. 29 indexed citations
14.
Korn, Joseph H., et al.. (1994). Lymphocyte modulation of fibroblast function in systemic sclerosis. Clinics in Dermatology. 12(3). 369–377. 16 indexed citations
15.
Korn, Joseph H.. (1991). Immunologic aspects of scleroderma. Current Opinion in Rheumatology. 3(6). 947–952. 16 indexed citations
16.
Korn, Joseph H., et al.. (1990). ICAM-1-dependent fibroblast-lymphocyte adhesion: Discordance between surface expression and function of ICAM-1. Cellular Immunology. 129(1). 125–137. 41 indexed citations
17.
Lorenzo, Joseph, et al.. (1990). Production of both interleukin-lα and ß by newborn mouse calvarial cultures. Journal of Bone and Mineral Research. 5(1). 77–83. 29 indexed citations
18.
Korn, Joseph H., et al.. (1989). Clonal interactions in fibroblast proliferation: Recognition of self vs. non‐self. Journal of Cellular Physiology. 141(2). 437–440. 8 indexed citations
19.
Padula, Steven J., Robert B. Clark, & Joseph H. Korn. (1986). Cell-mediated immunity in rheumatic disease. Human Pathology. 17(3). 254–263. 19 indexed citations
20.
Shanahan, William, et al.. (1985). Endothelial Cells Enhance the Human Pokeweed Mitogen Lymphocyte Response. Journal of Leukocyte Biology. 37(3). 305–317. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026